EXAS Share Price

Open 19.22 Change Price %
High 19.38 1 Day 0.00 0.00
Low 18.76 1 Week 1.47 8.37
Close 19.04 1 Month 4.70 32.78
Volume 3369080 1 Year 12.42 187.61
52 Week High 22.80
52 Week Low 4.67
EXAS Important Levels
Resistance 2 19.61
Resistance 1 19.38
Pivot 19.06
Support 1 18.70
Support 2 18.47
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
DRYS 1.87 0.00%
ACAS 17.99 0.39%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
LINE 0.18 12.50%
ATEA 1.90 11.76%
ATEA 1.90 11.76%
KITD 0.30 11.11%
SGYPU 10.75 10.26%
LPHI 0.24 9.09%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
THTI 0.15 -40.00%
More..

EXACT Sciences Corporation (NASDAQ: EXAS)

EXAS Technical Analysis 5
As on 13th Jan 2017 EXAS Share Price closed @ 19.04 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 12.78 & Strong Buy for SHORT-TERM with Stoploss of 15.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
EXAS Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
EXAS Other Details
Segment EQ
Market Capital 594952448.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.exactsciences.com
EXAS Address
EXAS
441 Charmany Drive
Madison, WI 53719
United States
Phone: 608-284-5700
Fax: 608-284-5701
EXAS Latest News
Interactive Technical Analysis Chart EXACT Sciences Corporation ( EXAS NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on EXACT Sciences Corporation
EXAS Business Profile
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The Company�s Cologuard test is a non-invasive, stool-based DNA (sDNA) screening test designed to detect deoxyribonucleic acid (DNA) markers, which in published studies have been shown to be associated with colorectal cancer. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test (FIT). The Company�s Cologuard test is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. The target sensitivity rate of its Cologuard test for cancer is equal to or greater than 85% at a specificity of 90%.